Neurophotonic methods have found great success in translational and clinical research. Commercialization of these methods is often paramount for clinical use. This panel will touch upon opportunities and difficulties with commercialization. Topics will include discussing different approaches to engaging and building trust within the research community, comparing and contrasting academic research vs. research at a startup, strategies for tackling challenges with clinical certification, including FDA approval and other regulatory hurdles, and personal experiences by the panelists.

Moderator:
Jana M. Kainerstorfer, Carnegie Mellon Univ. (United States)

Panelists:
Michele Lacerenza, PIONIRS s.r.l. (Italy)
Katherine L. Perdue, Kernel (United States)
Brad Hartl, Openwater (United States)
Robert J. Cooper, CoMind Technologies Ltd. (United Kingdom)

 

This panel is part of the Clinical and Translational Neurophotonics conference.

---

Event Details

FORMAT: Panel discussion followed by audience Q&A.
MENU: Coffee, decaf, and tea will be available outside the presentation room.
SETUP: Classroom and theater style seating.